Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma.
about
Molecular basis of targeted therapy in T/NK-cell lymphoma/leukemia: A comprehensive genomic and immunohistochemical analysis of a panel of 33 cell linesGenetics of Cutaneous T Cell Lymphoma: From Bench to Bedside.Langerhans, plasmacytoid dendritic and myeloid-derived suppressor cell levels in mycosis fungoides vary according to the stage of the disease.Report from the II Melanoma Translational Meeting of the Spanish Melanoma Group (GEM).Advances in the understanding and management of T-cell prolymphocytic leukemia.Fusion of the genes ataxin 2 like, ATXN2L, and Janus kinase 2, JAK2, in cutaneous CD4 positive T-cell lymphoma.Mutations in the JAK/STAT pathway genes and activation of the pathway, a relevant finding in nodal Peripheral T-cell lymphoma.S2k Guidelines - Cutaneous Lymphomas Update 2016 - Part 2: Treatment and Follow-up (ICD10 C82 - C86).S2k-Leitlinie - Kutane Lymphome Update 2016 - Teil 2: Therapie und Nachsorge (ICD10 C82 - C86).Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma
P2860
Q36372043-D7B8923D-2087-4BCF-BF2B-033474ECB288Q38855013-450A6ED3-F427-45C3-ACD9-13FF5DAB10E8Q38892071-A689E5CD-AEA8-45D9-8AC7-71EE05032F08Q45822425-00AC5CF4-1214-4D2D-A71B-905D94994379Q47113632-9C233622-55A7-446A-9361-84B6D8329485Q47270193-429A8091-64EB-496F-957F-61A2C0849C76Q48117678-87C98222-1CF1-4016-9E66-0300C8A6E0BCQ49561302-E67C97C4-1976-4A18-A937-C33BCB139177Q50122599-CB476D62-F3FD-4F82-93CF-40BC5548E6FCQ58742961-17949426-E140-4516-BDD8-C03371AC1F21
P2860
Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Mutated JAK kinases and deregu ...... in cutaneous T-cell lymphoma.
@en
Mutated JAK kinases and deregu ...... in cutaneous T-cell lymphoma.
@nl
type
label
Mutated JAK kinases and deregu ...... in cutaneous T-cell lymphoma.
@en
Mutated JAK kinases and deregu ...... in cutaneous T-cell lymphoma.
@nl
prefLabel
Mutated JAK kinases and deregu ...... in cutaneous T-cell lymphoma.
@en
Mutated JAK kinases and deregu ...... in cutaneous T-cell lymphoma.
@nl
P2093
P2860
P50
P1433
P1476
Mutated JAK kinases and deregu ...... s in cutaneous T-cell lymphoma
@en
P2093
Arantza Onaindia
Carmen Almaráz
Carmen González-Vela
Concepción Postigo
Cristina Pérez
Dolores Suárez-Massa
Helena Pisonero
Julia González-Rincón
Laura Cereceda
Mercedes Hospital
P2860
P304
P356
10.3324/HAEMATOL.2015.132837
P50
P577
2015-08-20T00:00:00Z